Collagen I and III, MMP-1 and TIMP-1 immunoexpression in dilated cardiomyopathy

Rom J Morphol Embryol. 2017;58(3):777-781.

Abstract

The extracellular matrix (ECM) remodeling represents the pathological substrate of dilated cardiomyopathy (DCM). In this study, we statistically analyzed the immunoexpression of collagen I and III, matrix metalloproteinase-1 (MMP-1) and its tissue inhibitor-1 (TIMP-1) in the myocardial tissue in 18 cases of DCM compared to a control group. We observed a significant increase in the immunoexpression of collagen I and III in patients with DCM and a significant reduction in the immunoexpression of MMP-1 compared with the control group. Also, the collagen I and TIMP-1 expression indicated a positive linear correlation and respectively a negative linear relationship with collagen III and MMP-1. The analyzed markers in this study can be used to quantify the degree of collagen sclerosis from the ECM of DCM.

MeSH terms

  • Cardiomyopathy, Dilated / genetics
  • Cardiomyopathy, Dilated / metabolism*
  • Cardiomyopathy, Dilated / pathology
  • Collagen Type I / biosynthesis*
  • Collagen Type I / genetics
  • Collagen Type III / biosynthesis
  • Collagen Type III / genetics
  • Humans
  • Matrix Metalloproteinase 1 / genetics
  • Tissue Inhibitor of Metalloproteinase-1 / biosynthesis*
  • Tissue Inhibitor of Metalloproteinase-1 / genetics

Substances

  • Collagen Type I
  • Collagen Type III
  • TIMP1 protein, human
  • Tissue Inhibitor of Metalloproteinase-1
  • MMP1 protein, human
  • Matrix Metalloproteinase 1